Log in
Enquire now
‌

US Patent 11203600 Kinase inhibitors and uses thereof

Patent 11203600 was granted and assigned to Denali Therapeutics on December, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Denali Therapeutics
Denali Therapeutics
Current Assignee
Denali Therapeutics
Denali Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11203600
Patent Inventor Names
Zachary K. Sweeney0
Javier De Vicente Fidalgo0
Jianwen A. Feng0
Maksim Osipov0
Anthony A. Estrada0
Arun Thottumkara0
Brian Fox0
Cheng Hu0
...
Date of Patent
December 21, 2021
Patent Application Number
16684340
Date Filed
November 14, 2019
Patent Primary Examiner
‌
Brenda L Coleman
Patent abstract

The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11203600 Kinase inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.